Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Polyoxometalate nanoclusters act as broad-spectrum antioxidants to alleviate ischemic stroke by intrathecal injection

Zachary Rosenkrans, Shiyong Li, Dawei Jiang, Dalong NI, Jonathan Engle and Weibo Cai
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 6;
Zachary Rosenkrans
1University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiyong Li
2RESEARCH SCHOLAR MADISON WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dawei Jiang
3University of Wisconsin - Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dalong NI
3University of Wisconsin - Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Engle
4Medical Physics University of Wisconsin - Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weibo Cai
3University of Wisconsin - Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

6

Objectives: Stroke is the fifth leading cause of death in the United States, responsible for approximately 1 in 20 deaths. More than 87% of all strokes are an ischemic stroke, which is caused in part by the generation of reactive oxygen species (ROS) in the penumbra following ischemia/reperfusion injury (IRI). We aim to alleviate cerebral IRI by intrathecal injection of molybdenum-based nanoclusters (POM) for neuronal protection by acting as nanoantioxidants.

Methods: The antioxidant properties of POM were evaluated for hydrogen peroxide, superoxide anion, and hydroxyl radicals. POM was chelator-free radiolabeled with Zr-89 for PET imaging. The middle cerebral artery occlusion (MCAO) surgery model was Irats with the MCAO model, the biodistribution was studied by PET imaging. The efficacy of POM treatment was compared to sham, sham+POM, and PBS treated rats three days after MCAO was performed. Magnetic resonance imaging (MRI) and 2,3,5-triphenyltetrazolium chloride (TTC) staining were used to assess cerebral IRI. Oxidative stress in the brain tissue homogenate of each treatment group was evaluated by measuring levels of superoxide dismutase (SOD) and malondialdhyde (MDA). Additionally, since oxidative stress initiates inflammatory damage, levels of the proinflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured for each treatment group.

Results: PET imaging studies found that the accumulation of 89Zr-POM in the brain following intrathecal injection was 6.6 ± 1.6%ID/g, which was significantly higher than that in the heart, lung, liver, spleen, and kidney. MRI determined that the infarct area was greater for PBS treated rats compared to POM treated rats or sham groups, suggesting POM ameliorated cerebral damage. Compared with the sham groups, the PBS-treated group was found to have lower SOD and higher MDA levels due to oxidative stress from ischemic brain damage. However, treatment with POM nanoclusters recovered SOD and MDA levels similar to sham groups. Levels of IL-6 and TNF-α in the PBS-treated group were much higher than those in the sham groups. Importantly, the anti-oxidative effects of POM substantially decreased TNF-α and IL-6 levels. Conclusion: Intrathecal injection significantly improved the delivery and efficacy of POM nanoclusters to the brain, resulting in the rapid accumulation of POM nanoclusters in the ischemic penumbra. Due to this, we confirmed that the POM nanoclusters could be used as nano-antioxidants to inhibit oxidative stress as well as inflammatory damage effectively.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Polyoxometalate nanoclusters act as broad-spectrum antioxidants to alleviate ischemic stroke by intrathecal injection
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Polyoxometalate nanoclusters act as broad-spectrum antioxidants to alleviate ischemic stroke by intrathecal injection
Zachary Rosenkrans, Shiyong Li, Dawei Jiang, Dalong NI, Jonathan Engle, Weibo Cai
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 6;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Polyoxometalate nanoclusters act as broad-spectrum antioxidants to alleviate ischemic stroke by intrathecal injection
Zachary Rosenkrans, Shiyong Li, Dawei Jiang, Dalong NI, Jonathan Engle, Weibo Cai
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 6;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
  • 18F-Radiofluorination of Aryl C-H Bonds using a Tandem Ir C-H Borylation/Cu Radiofluorination Strategy
  • Grade and IDH genotype prediction in glioma by a hybrid PET/MR with FET-PET and DSC-PWI
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Center for Molecular Imaging Innovation & Translation (CMIIT) YIA Symposium

  • Intrathecal injection of aptamer-conjugated DNA framework for the treatment of cerebral ischemia/reperfusion injury.
  • Imaging activated immune response following therapeutic vaccination in an orthotopic glioma model with 89Zr-DFO-OX40 mAb PET
Show more Center for Molecular Imaging Innovation & Translation (CMIIT) YIA Symposium

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire